Used primarily in scientific research as a sigma receptor antagonist, particularly targeting sigma-2 receptors. It has been investigated for its potential in oncology due to its ability to induce apoptosis in cancer cells, especially in breast, lung, and glioma models. Shows activity in promoting lysosomal membrane permeabilization, leading to cell death, making it a compound of interest in developing new anticancer therapies. Also utilized as a pharmacological tool to study sigma receptor function in neurological and psychiatric conditions, though it has not advanced to clinical use in humans.